Peptide-based combination nanoformulations for cancer therapy

Area of Science:

• Oncology
• Nanomedicine
• Biotechnology

Background:

• Cancer therapy increasingly integrates biomolecules with conventional treatments for better outcomes.
• Peptides are promising biomolecules due to their specificity, low toxicity, and broad targeting capabilities.

Purpose of the Study:

• To review nanodelivery systems for peptide-based combination therapies in cancer treatment.
• To explore the integration of peptides with chemotherapy, immunotherapy, radiation, and hormone therapy using nanoformulations.

Main Methods:

• Review of current research on combination nanoformulations involving various peptide types.
• Analysis of therapeutic strategies utilizing anticancer peptides, targeting peptides, peptide nanocarriers, peptidomimetics, peptide hormones, and peptide vaccines.

Main Results:

• Nanoformulations enhance peptide therapy efficacy by improving tumor penetration, circulation time, and accumulation while reducing off-target toxicity.
• Diverse peptide-based nanoformulations show potential across multiple cancer treatment modalities.

Conclusions:

• Peptide-based nanodelivery systems represent a significant advancement in combination cancer therapy.
• Further research is needed to overcome challenges hindering the clinical translation of these promising nanotechnologies.